Willow Biosciences Revenue and Competitors

Calgary, AB CAN

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Willow Biosciences's estimated annual revenue is currently $4.3M per year.(i)
  • Willow Biosciences's estimated revenue per employee is $155,000

Employee Data

  • Willow Biosciences has 28 Employees.(i)
  • Willow Biosciences grew their employee count by 17% last year.

Willow Biosciences's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
SVP Research and DevelopmentReveal Email/Phone
3
Office ManagerReveal Email/Phone
4
Office ManagerReveal Email/Phone
5
Senior Office ManagerReveal Email/Phone
6
ControllerReveal Email/Phone
7
Principal ScientistReveal Email/Phone
8
Scientist II, ChemistryReveal Email/Phone
9
Scientist IIReveal Email/Phone
10
Research Associate : Molecular BiologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M1110%N/AN/A
#2
$4.3M568%$1.7MN/A
#3
$3M3915%N/AN/A
#4
$4.2M54-4%N/AN/A
#5
$14.4M9341%N/AN/A
#6
$4.5M2926%N/AN/A
#7
$0.9M12-8%N/AN/A
#8
$3.7M24-17%N/AN/A
#9
$8.7M56-8%$100KN/A
#10
$3.3M2162%$13.4MN/A
Add Company

What Is Willow Biosciences?

Our multidisciplinary team of world-leading discovery biologists, biochemists and geneticists is dedicated to harnessing the therapeutic potential of plants. We provide pure, consistent, and cost-effective production processes for our pharmaceutical partners developing treatments for a wide array of medical conditions, from PTSD to Parkinson's. We are pioneers in the biotechnology sector and have developed the only fully-integrated synthetic biology solution for opiate biosynthesis. We are now leveraging our unique design-build process--and our proven track record--to the biosynthesis of cannabinoids.

keywords:N/A

N/A

Total Funding

28

Number of Employees

$4.3M

Revenue (est)

17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Willow Biosciences News

2022-04-13 - Short Interest in Willow Biosciences Inc. (OTCMKTS:CANSF ...

Willow Biosciences Inc, a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care,...

2022-03-22 - WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND ...

Willow is a leading biotechnology company that develops and produces high-purity, plant derived ingredients for the consumer care, food and...

2022-03-22 - Willow Biosciences reports Q4 results

Willow Biosciences press release (OTCQX:CANSF): Q4 ended the year in a strong financial position, with ~$29.9M in working capital and $30.1M...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.3M2827%N/A
#2
$4.8M2827%N/A
#3
$2.8M28N/AN/A
#4
$4.8M2817%N/A
#5
$2.9M29N/AN/A